DSS vs RARE · rev $7.9M vs rev $350.0M
DSS Inc (DSS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
DSS Inc (DSS) is a packaging & containers company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported DSS revenue for 2026-06-30 was $7.9M. Net income was -$10.4M. Revenue was up 83.2% from 2026-03-31 to 2026-06-30. DSS currently screens at market cap $8.3M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
DSS currently screens at market cap $8.3M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the DSS and RARE stock pages for the full models.
Not investment advice.